Annual report pursuant to Section 13 and 15(d)

Capital Lease Obligation

v3.19.2
Capital Lease Obligation
12 Months Ended
Jun. 30, 2018
Capital Lease Obligation  
Leases of Lessee Disclosure [Text Block]

10.    Capital Lease Obligation

As discussed above, iBio CDMO is leasing its facility in Bryan, Texas as well as certain equipment from the Second Eastern Affiliate under a 34‑year sublease (the "sublease"). iBio CDMO began operations at the facility on December 22, 2015 pursuant to agreements between iBio CDMO and the Second Eastern Affiliate granting iBio CDMO temporary rights to access the facility. These temporary agreements were superseded by the Sublease Agreement, dated January 13, 2016, between iBio CDMO and the Second Eastern Affiliate. The 34‑year term of the sublease may be extended by iBio CDMO for a ten-year period, so long as iBio CDMO is not in default under the sublease. Under the sublease, iBio CDMO is required to pay base rent at an annual rate of $2,100,000, paid in equal quarterly installments on the first day of each February, May, August and November. The base rent is subject to increase annually in accordance with increases in the Consumer Price Index ("CPI"). The base rent under the Second Eastern Affiliate’s ground lease for the property is subject to adjustment, based on an appraisal of the property, in 2030 and upon any extension of the ground lease. The base rent under the sublease will be increased by any increase in the base rent under the ground lease as a result of such adjustments. iBio CDMO is also responsible for all costs and expenses in connection with the ownership, management, operation, replacement, maintenance and repair of the property under the sublease.

In addition to the base rent, iBio CDMO is required to pay, for each calendar year during the term, a portion of the total gross sales for products manufactured or processed at the facility, equal to 7% of the first $5,000,000 of gross sales, 6% of gross sales between $5,000,001 and $25,000,000, 5% of gross sales between $25,000,001 and $50,000,000, 4% of gross sales between $50,000,001 and $100,000,000, and 3% of gross sales between $100,000,001 and $500,000,000. However, if for any calendar year period from January 1, 2018 through December 31, 2019, iBio CDMO’s applicable gross sales are less than $5,000,000, or for any calendar year period from and after January 1, 2020, its applicable gross sales are less than $10,000,000, then iBio CDMO is required to pay the amount that would have been payable if it had achieved such minimum gross sales and shall pay no less than the applicable percentage for the minimum gross sales for each subsequent calendar year. Percentage rent amounted to $350,000 and $199,000 in 2019 and 2018, respectively.

Interest expense incurred under the capital lease obligation amounted to $1,900,000 and $1,915,000 in 2019 and 2018, respectively.

Future minimum payments under the capitalized lease obligations are due as follows:

 

 

 

 

 

 

 

 

 

 

 

Year ending on June 30:

    

Principal

    

Interest

    

Total

2020

 

$

212,898

 

$

1,887,102

 

$

2,100,000

2021

 

 

229,562

 

 

1,870,438

 

 

2,100,000

2022

 

 

247,531

 

 

1,852,469

 

 

2,100,000

2023

 

 

266,906

 

 

1,833,094

 

 

2,100,000

2024

 

 

287,798

 

 

1,812,202

 

 

2,100,000

Thereafter

 

 

23,639,442

 

 

30,435,558

 

 

54,075,000

 

 

 

  

 

 

  

 

 

  

Total minimum lease payments

 

 

24,884,137

 

$

39,690,863

 

$

64,575,000

Less: current portion

 

 

(212,898)

 

 

  

 

 

  

Long-term portion of minimum lease obligations

 

$

24,671,239